Literature DB >> 11250652

Effect of thyroxine administration on the IGF/IGF binding protein system in neonatal and adult thyroidectomized rats.

S Ramos1, L Goya, C Alvarez, M A Martín, A M Pascual-Leone.   

Abstract

The effects of different doses of thyroxine (T(4)) delivered by injection or s.c. pellet implantation on alterations of the IGF/IGF binding protein (IGFBP) system were studied in neonatal and adult thyroidectomized (Tx) rats. Body weight, blood glucose, plasma insulin, TSH and GH and pituitary GH content, as well as serum IGF-I, IGF-II, IGFBP-1, -2 and -3 and their liver mRNA expression were assayed. Pellet implantation with the smaller dose of T(4) (1.5 microg/100 g body weight (b.w.) per day) in Tx neonatal rats decreased serum IGF-I, -II and the 30 kDa complex of IGFBPs (IGFBP-1 and -2), and increased serum IGFBP-3. Only the larger dose of T(4) (3 microg/100 g b.w. per day) recovered liver mRNA expression of IGF-I and ensured euthyroid status as shown by the normalized levels of plasma TSH. The rapid increase of body weight and serum GH after T(4) administration indicated a high sensitivity to T(4) during the neonatal period. Serum and liver mRNA expression of IGFs and plasma insulin and GH recovered in adult Tx rats after pellet implantation of 1.75 microg/100 g b.w. per day throughout 10 days. The continuous replacement of T(4) by pellet seems to be the most suitable method for thyroid rehabilitation. A very good correlation was found between insulin and IGF-II in Tx neonates treated with T(4) but not between insulin and IGF-I in Tx adults. IGFBP-2 seems to be up-regulated by T(4) deprivation in neonatal and adult rats. Finally, a good correlation as well as a partial correlation were found between IGFs and thyroid hormones in both neonatal and adult Tx populations, suggesting a direct effect in vivo of T(4) on the hepatic secretion of IGFs, as previously suggested in vitro.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11250652     DOI: 10.1677/joe.0.1690111

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  3 in total

1.  Sensitivity of supplementation of thyroid hormone on treatment of idiopathic short-stature children during therapy with recombinant human growth hormone.

Authors:  Wei Wang; Shuqin Jiang; Zhirui Cui; Xiangyang Luo; Lingli Shi; Heli Zheng
Journal:  Front Med       Date:  2018-04-06       Impact factor: 4.592

2.  Thyroid regeneration: characterization of clear cells after partial thyroidectomy.

Authors:  Takashi Ozaki; Tsutomu Matsubara; Daekwan Seo; Minoru Okamoto; Kunio Nagashima; Yoshihito Sasaki; Suguru Hayase; Tsubasa Murata; Xiao-Hui Liao; Jeffrey Hanson; Jaime Rodriguez-Canales; Snorri S Thorgeirsson; Kennichi Kakudo; Samuel Refetoff; Shioko Kimura
Journal:  Endocrinology       Date:  2012-03-27       Impact factor: 4.736

Review 3.  Thyroid regeneration: how stem cells play a role?

Authors:  Shioko Kimura
Journal:  Front Endocrinol (Lausanne)       Date:  2014-04-14       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.